色花堂

Publications

• Bass猫res E, Endres BT, Montes-Bravo N, P茅rez-Soto N, Rashid T, Lancaster C, Begum K, Alam MJ, Paredes-Sabja D, Garey KW. Visualization of fidaxomicin association with the exosporium layer of Clostridioides difficile spores. Anaerobe. 2021 Feb 25;69:102352. doi: 10.1016/j.anaerobe.2021.102352.
• Bass猫res E, Begum K, Lancaster C, Gonzales-Luna AJ, Carlson TJ, Miranda J, Rashid T, Alam MJ, Eyre DW, Wilcox MH, Garey KW. In vitro activity of eravacyclin against common ribotypes of C. difficile. J Antimicrob Chemother. 2020 Oct 1;75(10):2879-2884.
• Bass猫res E*, Endres BT*, Khaleduzzaman M, Miraftabi F, Alam MJ, Vickers RJ, Garey KW. Impact on toxin production and cell morphology in C. difficile by ridinilazole (SMT19969), a novel treatment for C. diificile infection. J Antimicrob Chemother. 2016 May;71(5):1245-51.
• M Engevik, H Danhof, J Auchtung, BT Endres, W Ruan, E Bass猫res, Q Wu, M Nicholson, RA Luna, KW Garey, SE Crawford, MK Estes, R Lux, MB Yacyshyn, B Yacyshyn, T Savidge, R Britton, J Versalovic. Fusobacterium nucleatum adheres to Clostridioides difficile via the RadD adhesin to enhance biofilm formation in intestinal mucus. Gastroenterol 2021Mar;160(4):13011314.e8.doi:10.1053/j.gastro.2020.11.034.
• Begum K, Bass猫res E/, Miranda J, Lancaster C, Gonzales-Luna AJ, Carlson TJ, Rashid T, Eyre DW, Wilcox MH, Alam MJ, Garey KW. In vitro activity of Omadacycline, a new tetracycline analog, and comparators against C. difficile. J Antimicrob Chemother. 2020 Jul 22;64(8):e00522-20.